Neogen Corporation Long-Term Debt, Maturity, Year Five
Neogen Corporation (NEOG) had Long-Term Debt, Maturity, Year Five of $346.50 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2026-07-30
- 2026-05-31: Long-Term Debt, Maturity, Year Five $346.50M.
- 2025-05-31: Long-Term Debt, Maturity, Year Five $465.63M.
- 2024-05-31: Long-Term Debt, Maturity, Year Five $0.00.
- 2023-05-31: Long-Term Debt, Maturity, Year Five $515.94M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2026-05-31 | $346.50M 10-K · filed 2026-07-30 |
| 2025-05-31 | $465.63M 10-K · filed 2025-07-30 |
| 2024-05-31 | $0.00 10-K · filed 2024-07-30 |
| 2023-05-31 | $515.94M 10-K · filed 2023-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |